Skip to main content

Table 3 The element and extent of information that research participants wanted to receive

From: What information and the extent of information research participants need in informed consent forms: a multi-country survey

Element

Abbreviation

n

Extent of information

Mean

SE

SD

Median

IQR

1. General items

 1.1 Title of research

Title

(n = 2100)

4.33

0.021

0.941

5

(4–5)

 1.2 Name of researchers

Name

(n = 2091)

4.08

0.024

1.088

4

(4–5)

 1.3 Affiliation or organization of researchers

Affil

(n = 2083)

4.10

0.023

1.035

4

(4–5)

 1.4 Recognition that this is research

Resea

(n = 2095)

4.29

0.021

0.963

5

(4–5)

 1.5 Contact information regarding the research study

cInfo

(n = 2040)

4.29

0.020

0.899

5

(4–5)

 1.6 Contact information about the participant’s right

cInfoR

(n = 2035)

4.26

0.021

0.932

5

(4–5)

 1.7 Source of funds and sponsors

Spons

(n = 2082)

3.75

0.027

1.233

4

(3–5)

 1.8 Conflict of interest

Coi

(n = 2020)

3.79

0.027

1.228

4

(3–5)

2. Study-specific items

 2.1 Background and rationale of research

Backg

(n = 2084)

4.16

0.021

0.966

4

(4–5)

 2.2 Purpose of research

Purp

(n = 2093)

4.35

0.019

0.868

5

(4–5)

 2.3 Eligibility of the participant

Eligib

(n = 2104)

4.28

0.020

0.915

5

(4–5)

 2.4 Study design of research

Desig

(n = 2078)

3.96

0.023

1.071

4

(3–5)

 2.5 Interventions under investigation

Interv

(n = 2080)

4.37

0.020

0.895

5

(4–5)

 2.6 Common adverse effects of the intervention

coAE

(n = 2082)

4.45

0.019

0.857

5

(4–5)

 2.7 All possible adverse effects of the intervention

allAE

(n = 2086)

4.36

0.020

0.933

5

(4–5)

 2.8 Other options or alternative treatments

Altern

(n = 2088)

4.02

0.024

1.093

4

(3–5)

 2.9 Duration of the participant’s participation

Durat

(n = 2069)

4.17

0.021

0.971

4

(4–5)

 2.10 Schedule and procedure

Proc

(n = 2089)

4.29

0.020

0.894

5

(4–5)

 2.11 Identification of any experimental procedures

eProc

(n = 2075)

4.11

0.022

1.013

4

(4–5)

 2.12 Number of participants involved

Numb

(n = 2092)

3.58

0.027

1.218

4

(3–5)

 2.13 Criteria for termination

Term

(n = 2045)

4.23

0.022

0.975

4

(4–5)

3. Items related to the subject’s right

 3.1 Voluntary participation

Volun

(n = 2093)

4.19

0.022

1.014

4

(4–5)

 3.2 Consequence of withdrawal

cWith

(n = 2039)

4.04

0.024

1.097

4

(4–5)

 3.3 Right to receive new information

nInfo

(n = 2048)

4.25

0.020

0.927

4

(4–5)

4. Items related to risk-benefit

 4.1 Major foreseeable risk

mjRis

(n = 2077)

4.47

0.020

0.902

5

(4–5)

 4.2 Minor foreseeable risk

miRis

(n = 2077)

4.25

0.021

0.968

5

(4–5)

 4.3 Possibly unforeseeable risk

ufRis

(n = 2043)

4.27

0.024

1.064

5

(4–5)

 4.4 Direct health benefit

dBene

(n = 2088)

4.47

0.017

0.793

5

(4–5)

 4.5 Indirect benefit

iBene

(n = 2096)

4.31

0.019

0.865

5

(4–5)

 4.6 Societal benefit

sBene

(n = 2049)

4.30

0.020

0.901

5

(4–5)

 4.7 Post-trial benefit or provision

pBene

(n = 2048)

4.23

0.021

0.950

4

(4–5)

5. Items related to data and sample storage

 5.1 Confidentiality and the limit of confidentiality

Confi

(n = 2048)

4.29

0.022

0.984

5

(4–5)

 5.2 Storage of human material

Stora

(n = 2041)

3.97

0.025

1.148

4

(3–5)

 5.3 Reuse of human material

Reuse

(n = 2043)

4.04

0.025

1.113

4

(4–5)

6. Items related to monetary issues

 6.1 Payment and/or remuneration

Paym

(n = 2040)

3.85

0.026

1.156

4

(3–5)

 6.2 Anticipated expense

Expen

(n = 2025)

4.00

0.024

1.099

4

(4–5)

 6.3 Compensation for injury

Compe

(n = 2038)

4.32

0.020

0.912

5

(4–5)

  1. IQR interquartile range, SD standard deviation, SE standard error of the mean